L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection <em>in vitro</em>

○Motohiko Ogawa

3:20 PM - 5:00 PM

[26PO5-pm2-12] L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro

○Motohiko Ogawa¹, Mana Murae^2,3, Ryutaro Gemba^2,4, Takuya Irie^2,3, Masayuki Shimojima¹, Koji Noguchi³, Masayuki Saijo¹, Masayoshi Fukasawa² (1. Dept Virology1, NIID, 2. Dept Biochemistry and Cell Biology, NIID, 3. Fac Pharma. Sci., Tokyo Univ. of Science, 4. Fac Sci., Tokyo Univ. of Science)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[26PO5-pm2] Immune system and biological defense

[26PO5-pm2-12] L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro

Password